Sponsored by
The committee voted for approval of the Novocure TTF100A device for the treatment of recurrent glioblastoma multiforme as a monotherapy!
The FDA will review the vote and make a final decision in a few weeks, but most of the time, they go with the committee recomendations!
I would like to thank all of our members who wrote letters -I presented them to the committee and was told that they made a big impact!
Al